These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 30633156)
1. CALD1, CNN1, and TAGLN identified as potential prognostic molecular markers of bladder cancer by bioinformatics analysis. Liu Y; Wu X; Wang G; Hu S; Zhang Y; Zhao S Medicine (Baltimore); 2019 Jan; 98(2):e13847. PubMed ID: 30633156 [TBL] [Abstract][Full Text] [Related]
2. MYLK and CALD1 as molecular targets in bladder cancer. Jin H; Liu B; Guo X; Qiao X; Jiao W; Yang L; Song X; Wei Y; Jin T Medicine (Baltimore); 2023 Nov; 102(47):e36302. PubMed ID: 38013282 [TBL] [Abstract][Full Text] [Related]
3. Screening and identification of key genes and pathways in metastatic uveal melanoma based on gene expression using bioinformatic analysis. Xie J; Wu Z; Xu X; Liang G; Xu J Medicine (Baltimore); 2020 Oct; 99(43):e22974. PubMed ID: 33120861 [TBL] [Abstract][Full Text] [Related]
4. Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis. Chen B; Sun D; Qin X; Gao XH Invest New Drugs; 2021 Aug; 39(4):928-948. PubMed ID: 33501609 [TBL] [Abstract][Full Text] [Related]
5. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer. Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036 [TBL] [Abstract][Full Text] [Related]
6. Identification of Hub Genes Associated with Progression and Prognosis of Bladder Cancer by Integrated Bioinformatics Analysis. Jiang S; Ma J; Wei S; Ren P; Liu J; Zhou Y; Liu D; Zhang X Arch Esp Urol; 2022 Nov; 75(9):779-790. PubMed ID: 36472061 [TBL] [Abstract][Full Text] [Related]
7. Integrated Network Analysis to Determine CNN1, MYL9, TAGLN, and SORBS1 as Potential Key Genes Associated with Prostate Cancer. Li C; Pang L; Jin F; Song Y; Zhou D; Song Y; Li Y; Jin S; Zhang L; Liang W; Shen X; Li J; She B; Wang C; Ma L Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436378 [TBL] [Abstract][Full Text] [Related]
8. Hub biomarkers in ultrasound-guided bladder cancer and osteosarcoma: Myosin light chain kinase and caldesmon. Li H; Lin G; Cui M; Wang L; Ding D; Li X; Fan X; Yang Q; Wang Y; Kang C; Zhang L; Liu B; Su J Medicine (Baltimore); 2023 Dec; 102(48):e36414. PubMed ID: 38050320 [TBL] [Abstract][Full Text] [Related]
9. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis. Shang M; Zhang L; Chen X; Zheng S Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587 [TBL] [Abstract][Full Text] [Related]
10. Integrated bioinformatics analyses identifying potential biomarkers for type 2 diabetes mellitus and breast cancer: In SIK1-ness and health. Durrani IA; Bhatti A; John P PLoS One; 2023; 18(8):e0289839. PubMed ID: 37556419 [TBL] [Abstract][Full Text] [Related]
11. Identification of key biomarkers and functional pathways in osteosarcomas with lung metastasis: Evidence from bioinformatics analysis. Liu D; Zhou R; Zhou A Medicine (Baltimore); 2021 Feb; 100(6):e24471. PubMed ID: 33578541 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of biomarkers for prostate cancer based on weighted gene co-expression network analysis. Chen X; Wang J; Peng X; Liu K; Zhang C; Zeng X; Lai Y Medicine (Baltimore); 2020 Apr; 99(14):e19628. PubMed ID: 32243390 [TBL] [Abstract][Full Text] [Related]
13. Identifying the mRNAs associated with Bladder cancer recurrence. Cao H; Cheng L; Yu J; Zhang Z; Luo Z; Chen D Cancer Biomark; 2020; 28(4):429-437. PubMed ID: 32390597 [TBL] [Abstract][Full Text] [Related]
14. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis. Li F; Guo P; Dong K; Guo P; Wang H; Lv X J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342 [No Abstract] [Full Text] [Related]
15. Identification of differentially expressed genes and biological pathways in bladder cancer. Tang F; He Z; Lei H; Chen Y; Lu Z; Zeng G; Wang H Mol Med Rep; 2018 May; 17(5):6425-6434. PubMed ID: 29532898 [TBL] [Abstract][Full Text] [Related]
16. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis. Yu-Jing T; Wen-Jing T; Biao T Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534 [TBL] [Abstract][Full Text] [Related]
17. Identification of key genes and pathways in pelvic organ prolapse based on gene expression profiling by bioinformatics analysis. Zhou Q; Hong L; Wang J Arch Gynecol Obstet; 2018 May; 297(5):1323-1332. PubMed ID: 29546564 [TBL] [Abstract][Full Text] [Related]
18. High S100A7 expression is associated with early muscle invasion and poor survival in bladder carcinoma. Dong Y; Zhu GY; Hao L; Liang Q; Zhou JH; Shi ZD; Yu H; Ma WM; Fan T; Zhang WD; Zang GH; Han CH Ann Diagn Pathol; 2022 Feb; 56():151847. PubMed ID: 34742033 [TBL] [Abstract][Full Text] [Related]
19. Identification of potential DNA methylation biomarkers related to diagnosis in patients with bladder cancer through integrated bioinformatic analysis. Cheng H; Liu Y; Chen G BMC Urol; 2023 Aug; 23(1):135. PubMed ID: 37563710 [TBL] [Abstract][Full Text] [Related]
20. Extracellular matrix-related genes play an important role in the progression of NMIBC to MIBC: a bioinformatics analysis study. Zhang H; Shan G; Song J; Tian Y; An LY; Ban Y; Luo GH Biosci Rep; 2020 May; 40(5):. PubMed ID: 32391563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]